The Ignored Symptom: Sleep Dysfunction in Neurodegenerative Diseases
Tonight nearly 750 million people in Europe will put on their pajamas, lay in their beds, close their eyes and try to fall into a deep and restful sleep. However, 35% of these people will lay awake, toss and turn and have disrupted and unsatisfying sleep. The morning after a restless night is usually met […]
New Paper Published on Fatigue and Sleep Assessment through Digital Wearables
Our newly published research presents results on using wearable sensing technology to assess fatigue and sleep in patients with chronic diseases. The article provides clinicians with insights on monitoring patients in the natural everyday settings of a patient’s daily life. In the future, wearable sensors could capture the effect the disease has on the patient’s […]
Sleepless society – The socioeconomic burden of sleep disturbances
“Being up with the lark”, “the early bird catches the worm”, or “being a night owl” – these phrases are all familiar. A work-focused and digitally connected culture produces the notion of constant availability and the pressure of maximizing time, even if this comes at the expense of our sleep. Looking at sleep patterns, there is a trend towards shorter […]
Benefits of IDEA-FAST outcomes for those affected by fatigue und sleep disorders
My family and I moved from southern Germany to northern Germany four years ago. It is beautiful here. However, there is something that I perceive as incriminating: In winter, there is about one hour less daylight than in the south of Germany. I have the feeling that the lack of this time of daylight makes […]
The IDEA-FAST feasibility study – Finding the most promising digital measures for sleep disturbances and fatigue
The aim of the feasibility study, which started in July this year, is to gather information on a variety of potential digital measures captured with different devices and their ability of reflecting sleep disturbances or fatigue. Apart from comparing data between different measures from patients with neurodegenerative disorders or immune-mediated inflammatory diseases as well as […]
